US 8980266
Serpin fusion polypeptides and methods of use thereof
granted A61KA61K38/00A61P
Quick answer
US patent 8980266 (Serpin fusion polypeptides and methods of use thereof) held by Inhibrx, Inc. expires Mon Mar 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Inhibrx, Inc.
- Grant date
- Tue Mar 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61K, A61K38/00, A61P, A61P1/00, A61P1/04